NDC 17856-0353-2 - Pharbetol Regular strength

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
17856-0353
Requested NDC
17856-0353-2
Package NDCs from labels
17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Effective date
2025-06-05
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
PHARBEST IBUPROFEN Drug FactsATLANTIC BIOLOGICALS CORP.2025-06-05HUMAN OTC DRUG LABEL
Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONSATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS2024-04-30HUMAN OTC DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
17856-0353-12024-06-26C16284748780-11030e365-250f-111a-e063-dadaa90a10e2PHARBEST IBUPROFEN Drug Facts
17856-0353-12024-01-30C16284748780-11030e365-250f-111a-e063-dadaa90a10e2PHARBEST IBUPROFEN Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-0353-1PharbetolRegular strength100 in 1 BOX, UNIT-DOSETABLET1003
17856-0353-2PharbetolRegular strength1 in 1 POUCHTABLET13
17856-0353-4PharbetolRegular strength24 in 1 BOTTLETABLET243
17856-0353-3PharbetolRegular strength28 in 1 BOTTLETABLET281

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-0353PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.]2Current NDC, Legacy NDC, 3 package rows20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip
17856-0353PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.]1Current NDC, Legacy NDC, 1 package rows20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 174 of 195 · 3,887 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Good Sense Effervescent Pain ReliefASPIRINPerrigo Direct, Inc.103027a7-2f0e-8d8c-e063-6294a90aedc72024-03-26WarningsExact identifier
application number: M013
Pure Cornstarch BabyCORN STARCHWalgreen Companyd0e9bd13-b568-4f7e-b036-8d23e71ad8bf2024-03-25WarningsExact identifier
unii: O8232NY3SJ
rugby infants acetaminophenACETAMINOPHENRugby Laboratories8aa9ac68-ca61-4163-a876-52034138c1ea2024-03-25WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Equate Pain Reliever Acetaminophen for Adults 250 mgACETAMINOPHENWalmart Inc08a18481-f029-f01f-e063-6294a90aac652024-03-21WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Equate Pain Reliever Acetaminophen for Adults 250 mgACETAMINOPHENWalmart Inc0d106fa2-2a77-deb2-e063-6394a90a2dac2024-03-21WarningsExact identifier
application number: M013
unii: 362O9ITL9D
AcetaminophenACETAMINOPHEN TABLET EXTENDED RELEASETIME CAP LABORATORIES, INC.cd4d0ad4-7206-94c8-e053-2a95a90aaa142024-03-19WarningsExact identifier
unii: 362O9ITL9D
Cold and Flu Relief NighttimeACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEDolgencorp, Inc. (DOLLAR GENERAL & REXALL)06d47104-a8ca-48cc-b27e-08c9d018c37b2024-03-19WarningsExact identifier
unii: 362O9ITL9D
Cold and Flu NighttimeACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEDolgencorp, Inc. (DOLLAR GENERAL & REXALL)b80dae7f-ed2d-4a9e-bef9-f1ed8add01742024-03-19WarningsExact identifier
unii: 362O9ITL9D
Good Sense Dual Action Back PainACETAMINOPHEN, IBUPROFENL. Perrigo Company89476188-cf88-4184-a366-ed4c2e7db1452024-03-19WarningsExact identifier
unii: 362O9ITL9D
Pain Relief Extra StrengthACETAMINOPHENEQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)872c5220-a379-4dc1-b99c-f11ebb82db352024-03-19WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Pain Reliever PM Extra StrengthACETAMINOPHEN, DIPHENHYDRAMINE HCLEQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)79886972-47a4-44c5-a131-1a691a3281032024-03-19WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Headache Relief Extra StrengthACETAMINOPHEN, ASPIRIN, CAFFEINEDolgencorp, Inc. (DOLLAR GENERAL & REXALL)5ffcc78d-9163-4cb4-8811-ae9f0142806a2024-03-18WarningsExact identifier
application number: M013
unii: 362O9ITL9D
ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVERASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVERHF Acquisition Co LLC, DBA HealthFirst13e621dc-b2b4-98fd-e063-6394a90acc752024-03-17WarningsExact identifier
application number: M013
ANTIGRIP DaytimeACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLPharmadel LLC12f20aba-f991-bd82-e063-6294a90a4aac2024-03-16WarningsExact identifier
unii: 362O9ITL9D
Arthritis Pain AcetaminophenACETAMINOPHENTARGET CORPORATIONc8025c83-77a1-c0dd-e053-2995a90a838d2024-03-15WarningsExact identifier
unii: 362O9ITL9D
8HR Pain ReliefACETAMINOPHENTARGET CORPORATIONe8b48f37-6023-ba04-e053-2a95a90a0e6c2024-03-15WarningsExact identifier
unii: 362O9ITL9D
Nighttime Cold and FluACETAMINOPHEN DEXTROMETHORPHAN HBR DOXYLAMINE SUCCINATEWALGREENSd3053f80-aece-eb50-e053-2a95a90a59452024-03-15WarningsExact identifier
unii: 362O9ITL9D
Daytime Cold and FluACETAMINOPHINE DEXTROMETHORPHAN HBR PHENYLPHRINE HCLWALGREENSd315bc95-1b46-75df-e053-2a95a90a6c662024-03-15WarningsExact identifier
unii: 362O9ITL9D
Arthritis Pain RelieverACETAMINOPHENWALGREENSe71f632f-37dd-49c0-e053-2a95a90a67d72024-03-15WarningsExact identifier
unii: 362O9ITL9D
Childrens Pain and FeverACETAMINOPHENCVS PHARMACY, INC097a9c98-a092-400d-9600-6797b0b9a50c2024-03-15WarningsExact identifier
application number: M013
unii: 362O9ITL9D

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.